No results for ‘’
Norris Medicines Ltd
₹16.30
(4.96%)
Tue, 06 Oct 2026, 07:21 pm
Health Technology
Pharmaceuticals: Major
24.5KNorris Medicines Price to Cash Flow Ratio
No Result Found
| Particulars |
|---|
| Price to earnings ratio |
| Price to book ratio |
| Price to sales ratio |
| Price to cash flow ratio |
| Enterprise value |
| Enterprise value to EBITDA ratio |
| Debt to equity ratio |
| Return on equity % |
Norris Medicines Ltd Price to Cash Flow Ratio
The Norris Medicines Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Norris Medicines Ltd's valuation, profitability, and overall financial performance. Tracking the Norris Medicines Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Norris Medicines Ltd (NSE: , BSE: 524414) is currently trading at ₹16.30, with a market capitalization of ₹0. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Norris Medicines Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Norris Medicines Ltd Price to Cash Flow Ratio Current Value
The current Norris Medicines Ltd Price to Cash Flow Ratio stands at 0.
The Norris Medicines Ltd Price to Cash Flow Ratio remains stable, indicating consistent financial performance.
Norris Medicines Ltd Price to Cash Flow Ratio Historical Trend
The Norris Medicines Ltd Price to Cash Flow Ratio has shown the following historical trend:
The decline in Norris Medicines Ltd Price to Cash Flow Ratio indicates improving financial efficiency or better earnings growth.
What Norris Medicines Ltd Price to Cash Flow Ratio Indicates for Investors
The Norris Medicines Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Norris Medicines Ltd Price to Cash Flow Ratio Analysis Summary
The Norris Medicines Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Norris Medicines Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Norris Medicines Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.